tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BCRX Stock Latest News

BioCryst’s Strategic Acquisition of Astria Therapeutics: Enhancing HAE Portfolio with Navenibart
RatingsBioCryst’s Strategic Acquisition of Astria Therapeutics: Enhancing HAE Portfolio with Navenibart
2h ago
BCRX
BioCryst price target raised to $27 from $17 at Citizens JMP
PremiumThe Fly
BioCryst price target raised to $27 from $17 at Citizens JMP
2h ago
ATXS
BCRX
BioCryst reinstated with a Buy at TD Cowen
PremiumThe Fly
BioCryst reinstated with a Buy at TD Cowen
14h ago
ATXS
BCRX
BioCryst weakness presents ‘compelling’ buying opportunity, says RBC
PremiumThe Fly
BioCryst weakness presents ‘compelling’ buying opportunity, says RBC
16h ago
ATXS
BCRX
BioCryst’s Strategic Acquisition of ATXS: A Catalyst for Long-Term Growth and Profitability
PremiumRatings
BioCryst’s Strategic Acquisition of ATXS: A Catalyst for Long-Term Growth and Profitability
17h ago
BCRX
BioCryst’s Strategic Acquisition of Astria Therapeutics Boosts Market Position and Financial Outlook
PremiumRatingsBioCryst’s Strategic Acquisition of Astria Therapeutics Boosts Market Position and Financial Outlook
17h ago
BCRX
BioCryst price target raised to $15 from $14 at Jefferies
Premium
The Fly
BioCryst price target raised to $15 from $14 at Jefferies
17h ago
ATXS
BCRX
Astria Therapeutics downgraded to Hold from Buy at Jefferies
Premium
The Fly
Astria Therapeutics downgraded to Hold from Buy at Jefferies
19h ago
ATXS
BCRX
Midday Fly By: Big banks report beats, GM takes $1.6B EV charge
PremiumThe Fly
Midday Fly By: Big banks report beats, GM takes $1.6B EV charge
20h ago
C
F
Here’s Why Astria Therapeutics Stock (ATXS) Exploded Today
PremiumMarket News
Here’s Why Astria Therapeutics Stock (ATXS) Exploded Today
21h ago
BCRX
STXS
Morning Movers: Albertsons gains, Goldman falls after quarterly results
PremiumThe Fly
Morning Movers: Albertsons gains, Goldman falls after quarterly results
23h ago
GM
GS
Video: Banks, dealmakers highlight early movers
PremiumThe Fly
Video: Banks, dealmakers highlight early movers
23h ago
GM
PCH
BioCryst Announces Merger with Astria Therapeutics
PremiumCompany AnnouncementsBioCryst Announces Merger with Astria Therapeutics
1d ago
8K
BCRX
BioCryst to acquire Astria Therapeutics for $13.00 per share
Premium
The Fly
BioCryst to acquire Astria Therapeutics for $13.00 per share
1d ago
ATXS
BCRX
BioCryst to acquire Astria Therapeutics for $13.00 per share
Premium
The Fly
BioCryst to acquire Astria Therapeutics for $13.00 per share
1d ago
ATXS
BCRX
BioCryst to acquire Astria Therapeutics for $13.00 per share
PremiumThe Fly
BioCryst to acquire Astria Therapeutics for $13.00 per share
1d ago
ATXS
BCRX
BioCryst reports inducement grants under Nasdaq listing rule
PremiumThe Fly
BioCryst reports inducement grants under Nasdaq listing rule
12d ago
BCRX
BioCryst downgraded to In Line from Outperform at Evercore ISI
PremiumThe Fly
BioCryst downgraded to In Line from Outperform at Evercore ISI
14d ago
BCRX
BioCryst Sells European ORLADEYO Business for $250M
PremiumCompany Announcements
BioCryst Sells European ORLADEYO Business for $250M
14d ago
8K
BCRX
BioCryst completes sale of European ORLADEYO business for $250M
PremiumThe FlyBioCryst completes sale of European ORLADEYO business for $250M
14d ago
BCRX
BioCryst reports inducement grants under Nasdaq listing rule
Premium
The Fly
BioCryst reports inducement grants under Nasdaq listing rule
1M ago
BCRX
BioCryst’s Chief R&D Officer Resigns Amid CEO Decision
Premium
Company Announcements
BioCryst’s Chief R&D Officer Resigns Amid CEO Decision
2M ago
8K
BCRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >